Resource impact template
NICE has produced a resource impact template that incorporates the following technology appraisal guidance for maintenance treatment of uncontrolled chronic obstructive pulmonary disease with raised blood eosinophils:
- Mepolizumab for maintenance treatment of uncontrolled chronic obstructive pulmonary disease with raised blood eosinophils (2026) NICE technology appraisal guidance 1166
- Dupilumab for maintenance treatment of uncontrolled chronic obstructive pulmonary disease with raised blood eosinophils (2026) NICE technology appraisal guidance 1142
This page was last updated: